| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.003 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.004 |